In Depth
Research Roundup
Debbie Rigby rounds up the latest in research news Facilitators of and Barriers to Deprescribing Diabetes Medications in Older Adults Facilitators for deprescribing diabetes medications in older adults include patients’ …
Money for nothing
Many owners are not getting the full benefits from the 8CPA, and the state-based expanded scope programs, primarily due to apathy, which in turn is driven by a lack of …
The future has arrived
Artificial intelligence (AI) has arrived and is already disrupting many aspects of pharmacy and business practice. Should you resist or embrace this future? Pharmacists need to be exploring the opportunities …
Flashback Friday: Government may delist Valium
It’s September 1975 and armed with a Commonwealth-owned pharmaceutical company, the federal government is looking to make savings on the PBS The federal government is moving towards heavier restriction, and …
Research Roundup
Debbie Rigby rounds up the latest in research news Cardiovascular, kidney related, and weight loss effects of therapeutics for type 2 diabetes This living clinical practice guideline details the benefits …
Pharmacy ownership in Queensland is changing—are you ready?
Big changes are coming up and the time to act is now, writes Lachlan Ballinger There’s been a lot of confusion – and for good reason. The Pharmacy Business Ownership …
Seller’s market: Young buyers are back
Full scope optimism has brought a new cohort of buyers into the market, but supply has dropped, a conference has heard Younger buyers have signalled their intention to buy pharmacies …
Flashback Friday: Children ill from free laxatives
Dodgy marketing practices are far from a modern concept: how about free drug samples posted into letterboxes? It’s September 1935, and the Australasian Journal of Pharmacy has a couple of …
Research Roundup
Debbie Rigby rounds up the latest in research news First-line treatment of osteoporosis with osteoanabolic therapy Osteoanabolic drugs, which form new bone and restore bone microarchitecture, are recommended as first-line …
Looking into the benefits and disruptions of new tech
Pharmacist and technology innovator Robert Sztar has reflected on the impact that various technology disruptors may have on pharmacy When you first hear that disruption and pharmacy make a “perfect …
Medicinal cannabis: minimising harm in a changing landscape
Regulators have raised the alarm about soaring cannabis scripts, issuing new guidance in a bid to minimise patient harm and curb inappropriate prescribing. Kate Cowling reports on what’s happened—and what …
Lotions and lasers: the future of acne management
Technological advances and concerns over topical treatments are driving an evolution in the treatment of acne. Pharmacists’ have a crucial role in guiding patients through the available options Acne vulgaris …